Impact Analysis of Covid-19
The complete version of the REPORT will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.
Respiratory tract infection is any infection in the nose, sinuses around the nose, throat (pharynx), voice box (larynx), and windpipe (trachea), airways (bronchi) or lungs, which may occur anytime, usually beginning with cold. This infection is usually caused by bacteria and viruses. Virus prone respiratory tract infection are easily transmitted and very contagious while bacterial infection can also be developed during the course of an upper respiratory tract infection. Respiratory tract infection is generally divided into two categories- upper respiratory tract infection (infection in nose, throat, and pharynx) and lower respiratory tract infection (infection below the larynx).
Market Dynamics
The global respiratory tract infection market is expected to witness lucrative growth due to factors such as increasing prevalence of lung diseases, surge in geriatric population, and rising risk of pneumonia in children. According to the World Health Organization (WHO), respiratory syncytial virus (RSV) is responsible for around 30 million lower respiratory tract infection cases in children worldwide. The prevalence of such viral diseases is expected to drive growth of the global market over the forecast period.
Increasing air pollution can severely affect respiratory health of children as well as adults. Various studies have shown effects of air pollution that can exacerbate existing respiratory conditions such as asthma, COPD, and upper airway allergies.
However, adverse effects of using NSAIDs and antibiotics on patients suffering from respiratory tract infection may hinder growth of the market. In 2015, the U.S. Food and Drug Administration (FDA) increased the warning labels on over-the-counter NSAIDs to highlight elevated risks for heart attack and stroke.
Key features of the study:
This report provides in-depth analysis of the respiratory tract infection treatment market, market size (US$ Mn), and compound annual growth rate (CAGR (%)) for the forecast period (2018 – 2026), considering 2017 as the base year
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by the leading players
It profiles leading players in the global respiratory tract infection treatment market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
Key players covered as a part of this study include Abbott Laboratories, AstraZeneca, Plc, Abbvie Inc., Boehringer Ingelheim GmbH, Cipla Pharmaceutical Company, GlaxoSmithKline plc, Pfizer Inc., Merck & Co., Novartis AG, F. Hoffman La Roche Ltd, Sanofi, and Teva Pharmaceutical Industries Ltd.
Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
The global respiratory tract infection treatment market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors and suppliers for respiratory tract infection treatment market, research and consulting firms, new entrants, and financial analysts
Detailed Segmentation:
Global Respiratory Tract Infection Treatment Market, By Drug Class:
Antibiotics
Non-Steroidal Anti-Inflammatory Drug (NSAIDS)
Cough Suppressant
Nasal Decongestant
Others
Global Respiratory Tract Infection Treatment Market, By Disease Indication:
Upper Respiratory Tract Infection
Lower Respiratory Tract Infection
Global Respiratory Tract Infection Treatment Market, By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Global Respiratory Tract Infection Treatment Market, By Region:
North America
By Country:
U.S.
Canada
By Drug Class:
Antibiotics
Non-Steroidal Anti-Inflammatory Drug (NSAIDS)
Cough Suppressant
Nasal Decongestant
Others
By Disease Indication:
Upper Respiratory Tract Infection
Lower Respiratory Tract Infection
By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Europe
By Country:
U.K.
Germany
Italy
Spain
France
Russia
Rest of Europe
By Drug Class:
Antibiotics
Non-Steroidal Anti-Inflammatory Drug (NSAIDS)
Cough Suppressant
Nasal Decongestant
Others
By Disease Indication:
Upper Respiratory Tract Infection
Lower Respiratory Tract Infection
By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Asia Pacific
By Country:
Australia
India
China
Japan
ASEAN
South Korea
Rest of Asia Pacific
By Drug Class:
Antibiotics
Non-Steroidal Anti-Inflammatory Drug (NSAIDS)
Cough Suppressant
Nasal Decongestant
Others
By Disease Indication:
Upper Respiratory Tract Infection
Lower Respiratory Tract Infection
By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Latin America
By Country:
Brazil
Mexico
Argentina
Rest of Latin America
By Drug Class:
Antibiotics
Non-Steroidal Anti-Inflammatory Drug (NSAIDS)
Cough Suppressant
Nasal Decongestant
Others
By Disease Indication:
Upper Respiratory Tract Infection
Lower Respiratory Tract Infection
By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Middle East
By Country:
GCC
Israel
Rest of Middle East
By Drug Class:
Antibiotics
Non-Steroidal Anti-Inflammatory Drug (NSAIDS)
Cough Suppressant
Nasal Decongestant
Others
By Disease Indication:
Upper Respiratory Tract Infection
Lower Respiratory Tract Infection
By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Africa
By Country:
South Africa
Central Africa
North Africa
By Drug Class:
Antibiotics
Non-Steroidal Anti-Inflammatory Drug (NSAIDS)
Cough Suppressant
Nasal Decongestant
Others
By Disease Indication:
Upper Respiratory Tract Infection
Lower Respiratory Tract Infection
By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Company Profiles
Abbott Laboratories*
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
AstraZeneca, Plc
Abbvie Inc.
Boehringer Ingelheim GmbH
Cipla Pharmaceutical Company
GlaxoSmithKline plc
Pfizer Inc.
Merck & Co.
Novartis AG
F. Hoffman La Roche Ltd
Sanofi
Teva Pharmaceutical Industries Ltd.
“*” marked represents similar segmentation in other categories in the respective section.
Table of Contents
1. Research Objective and Assumption
o Research Objectives
o Assumptions
o Abbreviations
2. Market Overview
o Report Description
o Market Definition and Scope
o Executive Summary
o Market Snippet, By Drug Class
o Market Snippet, By Disease Indication
o Market Snippet, By Distribution Channel
o Market Snippet, By Region
o Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
o Market Dynamics
o Drivers
o Restraints
o Market Opportunities
o Impact Analysis
o Market Trends
o Key Developments
o Regulatory Scenario
o Pipeline Analysis
o Epidemiology
o PEST Analysis
o PORTER'S Analysis
4. Global Respiratory Tract Infection Treatment Market, By Drug Class, 2016-2026, (US$ Million)
o Introduction
o Market Share Analysis, 2018 and 2026 (%)
o Y-o-Y Growth Analysis, 2017-2026
o Segment Trends
o Antibiotics
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016-2026, (US$ Million)
o Non-Steroidal Anti-Inflammatory Drug (NSAIDS)
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016-2026, (US$ Million)
o Cough Suppressant
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016-2026, (US$ Million)
o Nasal Decongestant
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016-2026, (US$ Million)
o Others
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016-2026, (US$ Million)
5. Global Respiratory Tract Infection Treatment Market, By Disease Indication, 2016-2026, (US$ Million)
o Introduction
o Market Share Analysis, 2018 and 2026 (%)
o Y-o-Y Growth Analysis, 2017-2026
o Segment Trends
o Upper Respiratory Tract Infection
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016-2026, (US$ Million)
o Lower Respiratory Tract Infection
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016-2026, (US$ Million)
6. Global Respiratory Tract Infection Treatment Market, By Distribution Channel, 2016-2026, (US$ Million)
o Introduction
o Market Share Analysis, 2018 and 2026 (%)
o Y-o-Y Growth Analysis, 2017-2026
o Segment Trends
o Hospital Pharmacies
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016-2026, (US$ Million)
o Retail Pharmacies
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016-2026, (US$ Million)
o Online Pharmacies
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016-2026, (US$ Million)
7. Global Respiratory Tract Infection Treatment Market, By Region, 2016-2026, (US$ Million)
o Introduction
o Market Share Analysis, By Region, 2018 and 2026 (%)
o Y-o-Y Growth Analysis, By Region, 2016-2026
o Regional Trends
o North America
o Market Size and Forecast, By Drug Class, 2016-2026, (US$ Million)
o Market Size and Forecast, By Disease Indication, 2016-2026, (US$ Million)
o Market Size and Forecast, By Distribution Channel, 2016-2026, (US$ Million)
o Market Size and Forecast, By Country, 2016-2026, (US$ Million)
o U.S.
o Canada
o Europe
o Market Size and Forecast, By Drug Class, 2016-2026, (US$ Million)
o Market Size and Forecast, By Disease Indication, 2016-2026, (US$ Million)
o Market Size and Forecast, By Distribution Channel, 2016-2026, (US$ Million)
o Market Size and Forecast, By Country, 2016-2026, (US$ Million)
o U.K.
o Germany
o Italy
o France
o Spain
o Russia
o Rest of Europe
o Asia Pacific
o Market Size and Forecast, By Drug Class, 2016-2026, (US$ Million)
o Market Size and Forecast, By Disease Indication, 2016-2026, (US$ Million)
o Market Size and Forecast, By Distribution Channel, 2016-2026, (US$ Million)
o Market Size and Forecast, By Country, 2016-2026, (US$ Million)
o China
o Japan
o India
o ASEAN
o Australia
o South Korea
o Rest of Asia Pacific
o Latin America
o Market Size and Forecast, By Drug Class, 2016-2026, (US$ Million)
o Market Size and Forecast, By Disease Indication, 2016-2026, (US$ Million)
o Market Size and Forecast, By Distribution Channel, 2016-2026, (US$ Million)
o Market Size and Forecast, By Country, 2016-2026, (US$ Million)
o Brazil
o Mexico
o Argentina
o Rest of Latin America
o Africa
o Market Size and Forecast, By Drug Class, 2016-2026, (US$ Million)
o Market Size and Forecast, By Disease Indication, 2016-2026, (US$ Million)
o Market Size and Forecast, By Distribution Channel, 2016-2026, (US$ Million)
o Market Size and Forecast, By Country, 2016-2026, (US$ Million)
o North Africa
o Central Africa
o South Africa
o Middle East
o Market Size and Forecast, By Drug Class, 2016-2026, (US$ Million)
o Market Size and Forecast, By Disease Indication, 2016-2026, (US$ Million)
o Market Size and Forecast, By Distribution Channel, 2016-2026, (US$ Million)
o Market Size and Forecast, By Country, 2016-2026, (US$ Million)
o GCC Countries
o Israel
o Rest of Middle East
8. Competitive Landscape
o Heat Map Analysis
o Company Profiles
o Abbott Laboratories
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
o AstraZeneca, Plc
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
o Abbvie Inc.
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
o Boehringer Ingelheim GmbH
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
o Cipla Pharmaceutical Company
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
o GlaxoSmithKline Plc
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
o Pfizer Inc.
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
o Merck & Co.
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
o Novartis AG
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o F. Hoffman La Roche Ltd
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
o Teva Pharmaceutical Industries Ltd.
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
o Sanofi
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
o Analyst Views
9. Section
o References
o Research Methodology
o About us and Sales Contact
*Browse 25 market data tables and 22 figures on "Respiratory Tract Infection Treatment Market" - Global forecast to 2026".
